Julian P. Villacastin/LinkedIn
Sep 7, 2026, 18:31
Julian P. Villacastin: LAAC as a Treatment Option When Long-Term Anticoagulation Is Problematic
Julian P. Villacastin, Director of CardioRed1, Head of the Cardiology Department at Hospital Clínico San Carlos,shared a post on X about a recent article Elmir Omerovic and Björn Redfors co-authored, published in European Heart Journal, adding:
“CHAMPION-AF and CLOSURE-AF: reconciling contrasting results.
LAAC is a real treatment option for patients in whom long-term anticoagulation is genuinely problematic.”
Title: CHAMPION-AF and CLOSURE-AF: reconciling contrasting results
Authors: Elmir Omerovic, Björn Redfors
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 23, 2026, 07:17Nahush Chafekar: Anticoagulation Strategies in Haemodialysis Patients with AF
-
Oct 23, 2026, 07:15Jessica Garcia: Honored Among the Best Doctors of 2026
-
Oct 23, 2026, 07:07Reda Awad Abdelsalam: FXIa Inhibition for Stroke Prevention
-
Oct 23, 2026, 06:43Tim Blair: Improving DVT Awareness, Early Diagnosis, and Access to Treatment
-
Oct 22, 2026, 18:04Basem Goueli: Blood Clots in the NFL
-
Oct 22, 2026, 17:57Syed Ahmed: Viral Triggers of Immune Thrombocytopenia and Thrombosis
-
Oct 22, 2026, 17:49Valerie Tutwiler: Bridging Engineering and Medicine to Advance Thrombosis Research
-
Oct 22, 2026, 17:41Jesus Ardila Novoa: How Patient Education Can Transform Hemophilia Care
-
Oct 22, 2026, 17:30Filipe Gonçalves: Advancing Bleeding Disorder Diagnosis Through Multidisciplinary Collaboration